Marijuana Stock Movers For February 21, 2024
Portfolio Pulse from Benzinga Insights
Marijuana stock movements on February 21, 2024, saw significant gains and losses across the sector. Eastside Distilling led the gainers with a 47.52% increase, while Elixinol Wellness experienced the largest drop at 37.50%. Notable companies like Cara Therapeutics, Psychemedics, and Genetic Technologies also saw gains, whereas Neptune Wellness Solutions, Canopy Growth, and Aurora Cannabis were among the notable losers.
February 21, 2024 | 9:30 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Aurora Cannabis experienced a 3.12% decrease in its stock price, closing at $3.36.
Aurora Cannabis' stock decline may be due to negative market sentiment or company-specific issues, highlighting the sector's current challenges.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 90
NEGATIVE IMPACT
Canopy Growth shares fell by 3.95%, ending at $3.40 amid sector volatility.
The drop in Canopy Growth's stock price reflects the volatility in the cannabis sector, possibly due to regulatory news or market sentiment.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 90
NEGATIVE IMPACT
Neptune Wellness Solutions shares closed down 5.89% at $0.41, reflecting market challenges.
The decline in Neptune Wellness Solutions' stock price suggests market challenges or negative investor sentiment towards the company.
CONFIDENCE 85
IMPORTANCE 70
RELEVANCE 80
POSITIVE IMPACT
Cara Therapeutics shares increased by 4.22%, closing at $0.67.
Cara Therapeutics' stock gain reflects a positive market response, possibly due to favorable developments within the company or the broader cannabis industry.
CONFIDENCE 85
IMPORTANCE 70
RELEVANCE 80
POSITIVE IMPACT
Eastside Distilling shares surged 47.52%, closing at $1.49, leading the gainers in the marijuana stock sector.
The significant gain in Eastside Distilling's stock price indicates strong investor confidence and market reaction, likely due to positive company news or sector momentum.
CONFIDENCE 90
IMPORTANCE 90
RELEVANCE 100
POSITIVE IMPACT
Genetic Technologies saw a 3.06% rise in its stock price, closing at $2.02.
The gain in Genetic Technologies' shares could be attributed to favorable market conditions or positive company-specific news.
CONFIDENCE 80
IMPORTANCE 60
RELEVANCE 70
POSITIVE IMPACT
Psychemedics shares closed up 3.22% at $3.21, indicating investor interest.
The increase in Psychemedics' stock price suggests a positive investor sentiment towards the company, potentially driven by sector trends or company performance.
CONFIDENCE 80
IMPORTANCE 60
RELEVANCE 70